METLIFE INC current report, 24 September 2026

MetLife, Inc. Form 8-K Summary

Filing date: September 24, 2026. The filing provides preliminary Regulation FD disclosure regarding the quarter ending September 30, 2026. MetLife expects to release its third-quarter earnings and financial supplement on November 4, 2026.

Key Financial Information

  • Estimated variable investment income: At least $600 million pretax for the quarter ended September 30, 2026.
  • Full-year 2026 guidance: Approximately $1.6 billion pretax of variable investment income.
  • Variable investment income includes private equity, real estate and other funds, and prepayment fees.
  • The filing does not provide quarterly revenue, net income, cash flow, margins, debt, liquidity, or other financial statement metrics.

Changes and Comparisons

The filing compares the preliminary third-quarter variable investment income estimate with full-year 2026 guidance but does not provide a comparable prior-period amount or quantify a year-over-year change. The estimated quarterly amount represents at least approximately 38% of the full-year guidance, based on the figures disclosed.

Outlook, Risks, and Unusual Items

  • The results are preliminary, unaudited, and based on information available to management before completion of the quarter-end closing process.
  • Actual results could differ materially from the estimate and are not necessarily indicative of future results.
  • The disclosure is subject to risks and uncertainties described in MetLife’s SEC filings, including its risk factors.
  • The filing cautions investors not to infer undisclosed financial or operating results from the variable investment income estimate.
  • The disclosure is furnished under Item 7.01 and is not deemed filed for Section 18 purposes or incorporated by reference into other filings unless expressly stated.

Facts Investors Should Verify

  1. Confirm the final third-quarter 2026 variable investment income in the earnings release and quarterly financial supplement scheduled for November 4, 2026.
  2. Compare final results with the approximately $1.6 billion full-year 2026 guidance.
  3. Review the completed financial statements for net income, cash flow, capital, liquidity, debt, and other operating metrics not included in this 8-K.
  4. Assess the impact of private equity, real estate, other fund performance, and prepayment fees on variable investment income.
  5. Review subsequent disclosures for changes to guidance or material differences from the preliminary estimate.